CLRB
Cellectar Biosciences Inc.
Company Overview
| Mkt Cap | $16.60M | Price | $3.31 |
| Volume | 45.11K | Change | -2.51% |
| P/E Ratio | -0.4 | Open | $3.43 |
| Revenue | -- | Prev Close | $3.39 |
| Net Income | $-44.6M | 52W Range | $3.25 - $66.00 |
| Div Yield | N/A | Target | $47.00 |
| Overall | 36 | Value | 60 |
| Quality | 23 | Technical | 25 |
No chart data available
Stock Overview
Updated DailyCellectar Biosciences Inc. (CLRB) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.31 with a market capitalization of $16.60 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows CLRB with a volume of 45K shares. The stock opened up 1.18% from yesterday's close of $3.39. Current analyst estimates project earnings of $-10.38 per share for this year, with next year targeting $-6.02.
CLRB demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including RGRX, VBIV, GLYC, PRQR.
Key investment considerations for CLRB include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 1322.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:15 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLRB | $3.31 | -2.5% | 45.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cellectar Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW